Antihypertensive treatment in pregnant women with preeclampsia;Aktuelle aspekte in der antihypertensiven therapie bei schwangeren mit praeklampsie

Zentralblatt fur Gynakologie

Volumn 121, Issue 12, 1999, Pages 631-636

  Wacker, Jürgen ^a   Werner, P ^b   Schulz, M ^b   Henschel, B ^b   Bastert, G ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

Preeclampsia; Therapy; Urapidil

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANTIHYPERTENSIVE AGENT; CATECHOLAMINE; DIHYDRALAZINE; URAPIDIL;

ADRENERGIC RECEPTOR BLOCKING; ANTIHYPERTENSIVE THERAPY; CONFERENCE PAPER; DELIVERY; FEMALE; HUMAN; HYPERTENSION; PREECLAMPSIA; PREMATURE LABOR;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CLINICAL TRIALS; DIHYDRALAZINE; FEMALE; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; PIPERAZINES; PRE-ECLAMPSIA; PREGNANCY;

EID: 0033399121     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Ahokas RA, Sibai, Mabie WC, Anderson GD: Nifedipine does not adversely affect uteroplacental blood flow in the hypertensive term-pregnant rat. Am J Obstet Gynecol 159 (1988) 1440-1445
2. Ayromlooi J, Tobias M, Berg P, Leff R: The effects of diazoxide upon fetal and maternal hemodynamics and fetal brain function and metabolism. Pediatr Pharmacol 2 (1982) 293-304
3. Cody RJ, Tarazi RC, Bravo EL, Fouvan FM: Haemodynamics of orally active converting enzyme inhibitor (SQ-14.225) in hypertensive patients. Clin Sci Mol Med 55 (1978) 453-457
4. Dubois D, Petitcolas J, Temperville B: Treatment of hypertension in pregnancy with betaadrenoceptor antagonists. Br J Clin Pharmacol 13 (1982) 3375-3379
5. Grunewald C, Carlstrom H, Lunell NO: Dihydralazine in preeclampsia: acute effects an atrial natriuretic peptide concentration and feto-maternal hemodynamics. J Maternal-Fetal Med 3 (1993) 21-24
6. Hanssens M, Keirse MJNC, Vankelecom F, van Assche FA: Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 78 (1991) 128-135
7. Horwarth GR, Sens A, Venter C, Pattinson RC: Randomized controlled pilot study comparing urapidil to dihydralazine in the mangement of severe hypertension in pregnancy. Hypertension in pregnancy 16 (1997) 213-221
8. Kaaja R, Hilesmaa V, Holma K, Jarvenpaa AL: Maternal antihypertensive therapy with betablockers associated with poor outcome in very-low birthweight infants. Int J Gynecol Obstet 38 (1992) 195-199
9. Koch-Weser J: Vasodilator drugs in the treatment of hypertension. Arch Intern Med 133 (1974) 1017-1020
10. Kyle PM, Redman CWG: Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy. Drug Safety 7 (1992) 223-234
11. Lip GYH, Churchill D, Beevers M, Auckett A, Beevers DG: Angiotensin-converting-enzyme inhibitors in early pregnancy. Lancet 350 (1997) 1446-1447
12. Lipshitz J, Ahokas RA, Reynolds SL: The effect of hydralazine on placental perfusion in the spontaneously hypertensive rat. Am J Obstet Gynecol 156 (1987) 356-359
13. Moodley J, Gouwes E: A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy. Br J Obstet Gynecol 99 (1992) 727-730
14. Olivari MT, Bartorelli C, Polese A: Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation 59 (1979) 1056-1058
15. Parisi VM, Salinas J, Stockmar EJ: Fetal vascular responses to maternal nicardipine administration in the hypertensive ewe. Am J Obstet Gynecol 161 (1989) 1035-1039
16. Paterson-Brown S, Robson SC, Redfern N, Walkinshaw SA, De Swiet M: Hydralazine boluses for the treatment of severe hypertension in preeclampsia. Br J Obstet Gynaecol 101 (1994) 409-411
17. Redman CWG, Beilin L, Bonnar J, Ountstead MK: Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet II (1976) 753-756
18. Sibai B: Treatment of hypertension in pregnant women. N Engl J Med 335 (1996) 257-265
19. Schießer M, Zafiriou N, Schulz M, Bastert G, Wacker J: Dopplersonographische Befunde unter Therapie mit Urapdil. Zentrabl Gynakol 121 (1999) 611-616
20. Steffensen FH, Nielsen GL, Soerensen HAT, Diesen C, Olesen J: Pregnancy outcome with ACE-inhibitors use in early pregnancy. Lancet 351 (1998) 596
21. Vink GJ, Moodley, Philpott RH: Effect of dihydralazine on the fetus in the treatment of maternal hypertension. Obstet Gynecol 55 (1980) 519-522
22. Wacker J, Lewicka S, Haack D, Bastert G: Hypertension in pregnancy. J Steroid Biochem Molec Biol 45 (1993) 65-68
23. Wacker J, Müller J, Unkels R, Bastert G: Antihypertensive Therapie bei Schwangerschaftsinduzierter Hypertonie (SIH) mit Urapidil. Zentralbl Gynakol 116 (1994) 271-273
24. Wacker J, Werner P, Walter-Sack I, Bastert G: Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil. Nephrol Dial Transplant 13 (1998) 318-325
25. Wacker J, Unkels R, Bode Chr, Werner P, Bastert G: Schwangerschaft bei korrigierter Transposition der großen Arterien und Therapie mit ACE - Hemmern. Zentralbl Gynakol 120 (1998) 462-464
26. Wacker J, Schulz M, Sperandio M, Werner P, Linderkamp O, Bastert G: Antihypertensiva in der Schwangerschaft und Auswirkungen auf den Feten. Gynäk Praxis 24 (2000) im Druck
27. Walker JJ, Gant NF: Hypertension in pregnancy. London -Weinheim - New York: Chapman & Hall 1997
28. Wide-Swensson D, Montal S, Ingemarsson I: How Swedish obstetricians manage hypertensive disorders in pregnancy. A questionnaire study. Acta Obstet Gynecol Scand 3 (1994) 619-624